Page last updated: 2024-09-05
gr 144053 and vapiprost
gr 144053 has been researched along with vapiprost in 1 studies
Compound Research Comparison
| Studies (gr 144053) | Trials (gr 144053) | Recent Studies (post-2010) (gr 144053) | Studies (vapiprost) | Trials (vapiprost) | Recent Studies (post-2010) (vapiprost) |
|---|---|---|---|---|---|
| 21 | 1 | 2 | 129 | 17 | 2 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kanamaru, M; Kozawa, O; Matsuno, H; Nagashima, S; Uematsu, T | 1 |
Other Studies
1 other study(ies) available for gr 144053 and vapiprost
| Article | Year |
|---|---|
Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.
Topics: Animals; Aspirin; Biphenyl Compounds; Cricetinae; Fibrinolytic Agents; Heptanoic Acids; Male; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1999 |